WISCONSIN— Moderna asked the Food and Drug Administration Thursday to approve their pediatric COVID-19 vaccine for the youngest of American; researchers and doctors, including at those UW Health, celebrated the news.
“The vaccine itself is a two-dose vaccine at this point, separated by 28 days,” said Dr. Bill Hartman, the principal investigator for UW-Health’s Moderna pediatric COVID-19 vaccine trial. “The results nationally that have been released by Moderna show that the safety profile has been excellent.”
UW Health played a role in Moderna's testing process, helping the potential pediatric vaccine to get to this point.
"[It's] very protective against severe disease, hospitalization and long-term effects from COVID,” Dr. Hartman added.
Watch the entire interview above.